Aspira Women s Health inc (AWHL) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access AWHL Annual Balance Sheets →
Observing balance sheet movements over recent quarters helps explain how Aspira Women s Health inc adapts its asset base and funding mix.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent0.48
Cash & Short-term Investments0.00
Accounts receivable1.49
Inventories0.23
Prepaid Expense And Other Assets Current0.80
Total Current Assets2.80
Equipment/Property/Plant Net0.18
Intangible Assets0.25
Other Assets, Noncurrent1.02
Operating Lease Right Of Use Asset0.93
Total Assets4.44
Liabilities
Accounts Payable, Current AC2.75
Accrued Liabilities, Current AC1.58
Short-term Debt0.55
Other Liabilities, Current0.46
Total Current Liabilities5.34
Long-term debt1.16
Total Long-term Debt1.16
Other liabilities, Noncurrent5.19
Operating Lease Liability Current0.21
Operating Lease Liability Noncurrent0.96
Total Liabilities11.69
Stockholders' Equity
Common Stock Value0.05
Additional Paid In Capital Common Stock538.62
Retained Earnings / Accumulated Deficit-545.92
Defined Benefit Plan and Other4.25
Other Equity0.00
Common Stockholder's Equity-7.26
Total Stockholder's Equity-7.26
Liabilities & Stockholder's Equity4.44
4 historic quarters locked

Sign in to unlock the full Aspira Women s Health inc balance sheet history.

About Aspira Womens Health Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000926617-26-000054

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.